 | • レポートコード：B-GIR08C6507 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、βアドレナリン受容体作動薬の世界市場について調べ、まとめました。種類別セグメントは、イソプレナリン、ドブタミン、サルブタモール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール等、用途別セグメントは、等に区分しました。βアドレナリン受容体作動薬の世界市場概観、企業動向、企業別βアドレナリン受容体作動薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・βアドレナリン受容体作動薬の市場概観 ・βアドレナリン受容体作動薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・βアドレナリン受容体作動薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・βアドレナリン受容体作動薬の世界市場規模 ・βアドレナリン受容体作動薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・βアドレナリン受容体作動薬のアメリカ市場規模推移 ・βアドレナリン受容体作動薬のカナダ市場規模推移 ・βアドレナリン受容体作動薬のメキシコ市場規模推移 ・βアドレナリン受容体作動薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・βアドレナリン受容体作動薬のドイツ市場規模推移 ・βアドレナリン受容体作動薬のイギリス市場規模推移 ・βアドレナリン受容体作動薬のロシア市場規模推移 ・βアドレナリン受容体作動薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・βアドレナリン受容体作動薬の日本市場規模推移 ・βアドレナリン受容体作動薬の中国市場規模推移 ・βアドレナリン受容体作動薬の韓国市場規模推移 ・βアドレナリン受容体作動薬のインド市場規模推移 ・βアドレナリン受容体作動薬の東南アジア市場規模推移 ・βアドレナリン受容体作動薬の南米市場分析（ブラジル、アルゼンチン等） ・βアドレナリン受容体作動薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・βアドレナリン受容体作動薬の種類別分析/販売量、売上、市場シェア（イソプレナリン、ドブタミン、サルブタモール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール） ・βアドレナリン受容体作動薬の用途別分析/市場規模（） ・βアドレナリン受容体作動薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・βアドレナリン受容体作動薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global β Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of β Adrenoceptor Agonists.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the β Adrenoceptor Agonists market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the β Adrenoceptor Agonists market by product type and applications/end industries.
Market Segment by Companies, this report covers
Ivax Pharmaceuticals
Physicians Total Care
Baxter Healthcare
Sanofi
Pfizer
Bedford Laboratories
Novartis
Sterimax
Teligent
AstraZeneca
Hikma Pharmaceuticals
Av Kare
Impax Laboratories
PD-Rx Pharmaceuticals
Athenex Pharmaceutical Division
Teva
Marlex Pharmaceuticals
Lannett Company
West-Ward Pharmaceuticals
United Biomedical
Merck
Mylan
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Isoprenaline
Dobutamine
Salbutamol
Terbutaline
Salmeterol
Formoterol
Pirbuterol
Market Segment by Applications, can be divided into
Chronic Heart Failure
Myocardial Infarction
Postoperative Hypotension
Bronchial Asthma
Asthmatic Bronchitis
Emphysema
Others
Table of Contents
1 β Adrenoceptor Agonists Market Overview
1.1 Product Overview and Scope of β Adrenoceptor Agonists
1.2 Classification of β Adrenoceptor Agonists by Types
1.2.1 Global β Adrenoceptor Agonists Revenue Comparison by Types (2019-2024)
1.2.2 Global β Adrenoceptor Agonists Revenue Market Share by Types in 2018
1.2.3 Isoprenaline
1.2.4 Dobutamine
1.2.5 Salbutamol
1.2.6 Terbutaline
1.2.7 Salmeterol
1.2.8 Formoterol
1.2.9 Pirbuterol
1.3 Global β Adrenoceptor Agonists Market by Application
1.3.1 Global β Adrenoceptor Agonists Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Chronic Heart Failure
1.3.3 Myocardial Infarction
1.3.4 Postoperative Hypotension
1.3.5 Bronchial Asthma
1.3.6 Asthmatic Bronchitis
1.3.7 Emphysema
1.3.8 Others
1.4 Global β Adrenoceptor Agonists Market by Regions
1.4.1 Global β Adrenoceptor Agonists Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) β Adrenoceptor Agonists Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) β Adrenoceptor Agonists Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) β Adrenoceptor Agonists Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) β Adrenoceptor Agonists Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) β Adrenoceptor Agonists Status and Prospect (2014-2024)
1.5 Global Market Size of β Adrenoceptor Agonists (2014-2024)
2 Manufacturers Profiles
2.1 Ivax Pharmaceuticals
2.1.1 Business Overview
2.1.2 β Adrenoceptor Agonists Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Ivax Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.2 Physicians Total Care
2.2.1 Business Overview
2.2.2 β Adrenoceptor Agonists Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Physicians Total Care β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.3 Baxter Healthcare
2.3.1 Business Overview
2.3.2 β Adrenoceptor Agonists Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Baxter Healthcare β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 β Adrenoceptor Agonists Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 β Adrenoceptor Agonists Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bedford Laboratories
2.6.1 Business Overview
2.6.2 β Adrenoceptor Agonists Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bedford Laboratories β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novartis
2.7.1 Business Overview
2.7.2 β Adrenoceptor Agonists Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sterimax
2.8.1 Business Overview
2.8.2 β Adrenoceptor Agonists Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sterimax β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.9 Teligent
2.9.1 Business Overview
2.9.2 β Adrenoceptor Agonists Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teligent β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 β Adrenoceptor Agonists Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.11 Hikma Pharmaceuticals
2.11.1 Business Overview
2.11.2 β Adrenoceptor Agonists Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hikma Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.12 Av Kare
2.12.1 Business Overview
2.12.2 β Adrenoceptor Agonists Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Av Kare β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.13 Impax Laboratories
2.13.1 Business Overview
2.13.2 β Adrenoceptor Agonists Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Impax Laboratories β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.14 PD-Rx Pharmaceuticals
2.14.1 Business Overview
2.14.2 β Adrenoceptor Agonists Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 PD-Rx Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.15 Athenex Pharmaceutical Division
2.15.1 Business Overview
2.15.2 β Adrenoceptor Agonists Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Athenex Pharmaceutical Division β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.16 Teva
2.16.1 Business Overview
2.16.2 β Adrenoceptor Agonists Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Teva β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.17 Marlex Pharmaceuticals
2.17.1 Business Overview
2.17.2 β Adrenoceptor Agonists Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Marlex Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.18 Lannett Company
2.18.1 Business Overview
2.18.2 β Adrenoceptor Agonists Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Lannett Company β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.19 West-Ward Pharmaceuticals
2.19.1 Business Overview
2.19.2 β Adrenoceptor Agonists Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 West-Ward Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.20 United Biomedical
2.20.1 Business Overview
2.20.2 β Adrenoceptor Agonists Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 United Biomedical β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.21 Merck
2.21.1 Business Overview
2.2.2 β Adrenoceptor Agonists Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Merck β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.22 Mylan
2.22.1 Business Overview
2.22.2 β Adrenoceptor Agonists Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Mylan β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
3 Global β Adrenoceptor Agonists Market Competition, by Players
3.1 Global β Adrenoceptor Agonists Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 β Adrenoceptor Agonists Players Market Share
3.2.2 Top 10 β Adrenoceptor Agonists Players Market Share
3.3 Market Competition Trend
4 Global β Adrenoceptor Agonists Market Size by Regions
4.1 Global β Adrenoceptor Agonists Revenue and Market Share by Regions
4.2 North America β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
4.3 Europe β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
4.5 South America β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
5 North America β Adrenoceptor Agonists Revenue by Countries
5.1 North America β Adrenoceptor Agonists Revenue by Countries (2014-2019)
5.2 USA β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
5.3 Canada β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
5.4 Mexico β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
6 Europe β Adrenoceptor Agonists Revenue by Countries
6.1 Europe β Adrenoceptor Agonists Revenue by Countries (2014-2019)
6.2 Germany β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
6.3 UK β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
6.4 France β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
6.5 Russia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
6.6 Italy β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
7 Asia-Pacific β Adrenoceptor Agonists Revenue by Countries
7.1 Asia-Pacific β Adrenoceptor Agonists Revenue by Countries (2014-2019)
7.2 China β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
7.3 Japan β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
7.4 Korea β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
7.5 India β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
8 South America β Adrenoceptor Agonists Revenue by Countries
8.1 South America β Adrenoceptor Agonists Revenue by Countries (2014-2019)
8.2 Brazil β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
8.3 Argentina β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
8.4 Colombia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue β Adrenoceptor Agonists by Countries
9.1 Middle East and Africa β Adrenoceptor Agonists Revenue by Countries (2014-2019)
9.2 Saudi Arabia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
9.3 UAE β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
9.4 Egypt β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
9.5 Nigeria β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
9.6 South Africa β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
10 Global β Adrenoceptor Agonists Market Segment by Type
10.1 Global β Adrenoceptor Agonists Revenue and Market Share by Type (2014-2019)
10.2 Global β Adrenoceptor Agonists Market Forecast by Type (2019-2024)
10.3 Isoprenaline Revenue Growth Rate (2014-2024)
10.4 Dobutamine Revenue Growth Rate (2014-2024)
10.5 Salbutamol Revenue Growth Rate (2014-2024)
10.6 Terbutaline Revenue Growth Rate (2014-2024)
10.7 Salmeterol Revenue Growth Rate (2014-2024)
10.8 Formoterol Revenue Growth Rate (2014-2024)
10.9 Pirbuterol Revenue Growth Rate (2014-2024)
11 Global β Adrenoceptor Agonists Market Segment by Application
11.1 Global β Adrenoceptor Agonists Revenue Market Share by Application (2014-2019)
11.2 β Adrenoceptor Agonists Market Forecast by Application (2019-2024)
11.3 Chronic Heart Failure Revenue Growth (2014-2019)
11.4 Myocardial Infarction Revenue Growth (2014-2019)
11.5 Postoperative Hypotension Revenue Growth (2014-2019)
11.6 Bronchial Asthma Revenue Growth (2014-2019)
11.7 Asthmatic Bronchitis Revenue Growth (2014-2019)
11.8 Emphysema Revenue Growth (2014-2019)
11.9 Others Revenue Growth (2014-2019)
12 Global β Adrenoceptor Agonists Market Size Forecast (2019-2024)
12.1 Global β Adrenoceptor Agonists Market Size Forecast (2019-2024)
12.2 Global β Adrenoceptor Agonists Market Forecast by Regions (2019-2024)
12.3 North America β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
12.4 Europe β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
12.6 South America β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure β Adrenoceptor Agonists Picture
Table Product Specifications of β Adrenoceptor Agonists
Table Global β Adrenoceptor Agonists and Revenue (Million USD) Market Split by Product Type
Figure Global β Adrenoceptor Agonists Revenue Market Share by Types in 2018
Figure Isoprenaline Picture
Figure Dobutamine Picture
Figure Salbutamol Picture
Figure Terbutaline Picture
Figure Salmeterol Picture
Figure Formoterol Picture
Figure Pirbuterol Picture
Table Global β Adrenoceptor Agonists Revenue (Million USD) by Application (2014-2024)
Figure β Adrenoceptor Agonists Revenue Market Share by Applications in 2018
Figure Chronic Heart Failure Picture
Figure Myocardial Infarction Picture
Figure Postoperative Hypotension Picture
Figure Bronchial Asthma Picture
Figure Asthmatic Bronchitis Picture
Figure Emphysema Picture
Figure Others Picture
Table Global Market β Adrenoceptor Agonists Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America β Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe β Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific β Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America β Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa β Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global β Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Table Ivax Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ivax Pharmaceuticals β Adrenoceptor Agonists Type and Applications
Table Ivax Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Physicians Total Care Basic Information, Manufacturing Base and Competitors
Table Physicians Total Care β Adrenoceptor Agonists Type and Applications
Table Physicians Total Care β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table Baxter Healthcare β Adrenoceptor Agonists Type and Applications
Table Baxter Healthcare β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi β Adrenoceptor Agonists Type and Applications
Table Sanofi β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer β Adrenoceptor Agonists Type and Applications
Table Pfizer β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Bedford Laboratories Basic Information, Manufacturing Base and Competitors
Table Bedford Laboratories β Adrenoceptor Agonists Type and Applications
Table Bedford Laboratories β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis β Adrenoceptor Agonists Type and Applications
Table Novartis β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Sterimax Basic Information, Manufacturing Base and Competitors
Table Sterimax β Adrenoceptor Agonists Type and Applications
Table Sterimax β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Teligent Basic Information, Manufacturing Base and Competitors
Table Teligent β Adrenoceptor Agonists Type and Applications
Table Teligent β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca β Adrenoceptor Agonists Type and Applications
Table AstraZeneca β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Hikma Pharmaceuticals β Adrenoceptor Agonists Type and Applications
Table Hikma Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Av Kare Basic Information, Manufacturing Base and Competitors
Table Av Kare β Adrenoceptor Agonists Type and Applications
Table Av Kare β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Impax Laboratories Basic Information, Manufacturing Base and Competitors
Table Impax Laboratories β Adrenoceptor Agonists Type and Applications
Table Impax Laboratories β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table PD-Rx Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table PD-Rx Pharmaceuticals β Adrenoceptor Agonists Type and Applications
Table PD-Rx Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Athenex Pharmaceutical Division Basic Information, Manufacturing Base and Competitors
Table Athenex Pharmaceutical Division β Adrenoceptor Agonists Type and Applications
Table Athenex Pharmaceutical Division β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva β Adrenoceptor Agonists Type and Applications
Table Teva β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Marlex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Marlex Pharmaceuticals β Adrenoceptor Agonists Type and Applications
Table Marlex Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Lannett Company Basic Information, Manufacturing Base and Competitors
Table Lannett Company β Adrenoceptor Agonists Type and Applications
Table Lannett Company β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table West-Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table West-Ward Pharmaceuticals β Adrenoceptor Agonists Type and Applications
Table West-Ward Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table United Biomedical Basic Information, Manufacturing Base and Competitors
Table United Biomedical β Adrenoceptor Agonists Type and Applications
Table United Biomedical β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck β Adrenoceptor Agonists Type and Applications
Table Merck β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan β Adrenoceptor Agonists Type and Applications
Table Mylan β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Global β Adrenoceptor Agonists Revenue (Million USD) by Players (2014-2019)
Table Global β Adrenoceptor Agonists Revenue Share by Players (2014-2019)
Figure Global β Adrenoceptor Agonists Revenue Share by Players in 2017
Figure Global β Adrenoceptor Agonists Revenue Share by Players in 2018
Figure Global Top 5 Players β Adrenoceptor Agonists Revenue Market Share in 2018
Figure Global Top 10 Players β Adrenoceptor Agonists Revenue Market Share in 2018
Figure Global β Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global β Adrenoceptor Agonists Revenue (Million USD) by Regions (2014-2019)
Table Global β Adrenoceptor Agonists Revenue Market Share by Regions (2014-2019)
Figure Global β Adrenoceptor Agonists Revenue Market Share by Regions (2014-2019)
Figure Global β Adrenoceptor Agonists Revenue Market Share by Regions in 2018
Figure North America β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Europe β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure South America β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table North America β Adrenoceptor Agonists Revenue by Countries (2014-2019)
Table North America β Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure North America β Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure North America β Adrenoceptor Agonists Revenue Market Share by Countries in 2018
Figure USA β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Canada β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Mexico β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table Europe β Adrenoceptor Agonists Revenue (Million USD) by Countries (2014-2019)
Figure Europe β Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure Europe β Adrenoceptor Agonists Revenue Market Share by Countries in 2018
Figure Germany β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure UK β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure France β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Russia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Italy β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table Asia-Pacific β Adrenoceptor Agonists Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific β Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific β Adrenoceptor Agonists Revenue Market Share by Countries in 2018
Figure China β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Japan β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Korea β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure India β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Southeast Asia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table South America β Adrenoceptor Agonists Revenue by Countries (2014-2019)
Table South America β Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure South America β Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure South America β Adrenoceptor Agonists Revenue Market Share by Countries in 2018
Figure Brazil β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Argentina β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Colombia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table Middle East and Africa β Adrenoceptor Agonists Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa β Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa β Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa β Adrenoceptor Agonists Revenue Market Share by Countries in 2018
Figure Saudi Arabia β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure UAE β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Egypt β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Nigeria β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure South Africa β Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table Global β Adrenoceptor Agonists Revenue (Million USD) by Type (2014-2019)
Table Global β Adrenoceptor Agonists Revenue Share by Type (2014-2019)
Figure Global β Adrenoceptor Agonists Revenue Share by Type (2014-2019)
Figure Global β Adrenoceptor Agonists Revenue Share by Type in 2018
Table Global β Adrenoceptor Agonists Revenue Forecast by Type (2019-2024)
Figure Global β Adrenoceptor Agonists Market Share Forecast by Type (2019-2024)
Figure Global Isoprenaline Revenue Growth Rate (2014-2019)
Figure Global Dobutamine Revenue Growth Rate (2014-2019)
Figure Global Salbutamol Revenue Growth Rate (2014-2019)
Figure Global Terbutaline Revenue Growth Rate (2014-2019)
Figure Global Salmeterol Revenue Growth Rate (2014-2019)
Figure Global Formoterol Revenue Growth Rate (2014-2019)
Figure Global Pirbuterol Revenue Growth Rate (2014-2019)
Table Global β Adrenoceptor Agonists Revenue by Application (2014-2019)
Table Global β Adrenoceptor Agonists Revenue Share by Application (2014-2019)
Figure Global β Adrenoceptor Agonists Revenue Share by Application (2014-2019)
Figure Global β Adrenoceptor Agonists Revenue Share by Application in 2018
Table Global β Adrenoceptor Agonists Revenue Forecast by Application (2019-2024)
Figure Global β Adrenoceptor Agonists Market Share Forecast by Application (2019-2024)
Figure Global Chronic Heart Failure Revenue Growth Rate (2014-2019)
Figure Global Myocardial Infarction Revenue Growth Rate (2014-2019)
Figure Global Postoperative Hypotension Revenue Growth Rate (2014-2019)
Figure Global Bronchial Asthma Revenue Growth Rate (2014-2019)
Figure Global Asthmatic Bronchitis Revenue Growth Rate (2014-2019)
Figure Global Emphysema Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global β Adrenoceptor Agonists Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global β Adrenoceptor Agonists Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global β Adrenoceptor Agonists Revenue Market Share Forecast by Regions (2019-2024)
Figure North America β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
Figure Europe β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
Figure Asia-Pacific β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
Figure South America β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
Figure Middle East and Africa β Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
β2アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β2 Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …- β1アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β1 Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …
- 非選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Nonselective Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, als…
- 選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Selective Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also f…
- オピオイド耐性治療の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Opioids are effective analgesics prescribed to people with chronic cancer and severe pain. These opioids are generally used for short period of time. If these opioids are prescribed or taken for a longer period of time or more frequent daily doses, they create opioid tolerance in patients and hence,…